Clinical characteristics and short-term recovery of hyposmia in hospitalized non-severe COVID-19 patients with Omicron variant in Shanghai, China

被引:5
作者
Shen, Jun [1 ]
Wu, Li [1 ]
Wang, Ping [1 ]
Shen, Xiaolei [1 ]
Jiang, Yuhan [1 ]
Liu, Jianren [1 ]
Chen, Wei [1 ]
机构
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Neurol, Shanghai, Peoples R China
关键词
COVID-19; Omicron; hyposmia; IL-6; recovery;
D O I
10.3389/fmed.2022.1038938
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundOlfactory dysfunction is a common neurological symptom of Corona Virus Disease 2019(COVID-19). Little is known about hyposmia after COVID-19 infection with Omicron variant in Chinese population. ObjectiveTo investigate the incidence, clinical characteristics and recovery of hyposmia in hospitalized non-severe COVID-19 patients with Omicron variant in Shanghai, China. MethodsThree hundred and forty-nine Chinese non-severe COVID-19 patients with Omicron variant were consecutively enrolled in a designated hospital to investigate the incidence of hyposmia in hospitalization and the recovery rate 1 month later. The visual assessment scale (VAS) was used to evaluate the severity of hyposmia. We compared the demographic, clinical features and treatment outcomes, as well as laboratory parameters between patients with and without hyposmia. ResultsThe cross-sectional survey showed that 22 (6.3%) hospitalized patients with non-severe COVID-19 had hyposmia. Patients with hyposmia were younger (61.5 vs. 72.0, p = 0.002), had more related clinical symptoms (sore throat, cough, poor appetite, diarrhea, myalgia and taste impairment, etc.), a higher proportion of moderate clinical type (31.8 vs. 13.5%, p = 0.028) and longer duration of hospitalization (11 vs. 8 days, p = 0.027) than those without hyposmia. Whereas, there were no significant differences regarding gender, comorbidity and nucleic acid conversion time between the two groups. Laboratory subgroup analyses demonstrated that patients with hyposmia had slightly low serum IL-6 and TNF-alpha levels. However, both of the levels were not associated with hyposmia occurrence in multivariate regression analyses. Further follow-up study disclosed that 16 of 22 (72.7%) hyposmia patients had recovered olfaction 1 month later. Serum IL-6 and TNF-alpha levels were similar between hyposmia recovered patients and those with persistent hyposmia. ConclusionAlthough the incidence of hyposmia after Omicron variant infection is relatively low and the short-term recovery rate is quite high, patients with hyposmia are prone to have a higher proportion of both upper and lower respiratory tract involvements, gastrointestinal and neurological symptoms, contributing to a longer duration of hospitalization.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study
    Zhang Yitao
    Chen Mu
    Zhou Ling
    Cheng Shiyao
    Xue Jiaojie
    Chen Zhichong
    Peng Huajing
    Ou Maode
    Cheng Kanglin
    Ou Yang Mao
    Mo Xiaoneng
    Zeng Weijie
    CURRENT MEDICAL RESEARCH AND OPINION, 2021, 37 (03) : 385 - 391
  • [22] Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China
    Hu, Chen
    Liu, Yu-Kai
    Sun, Qi-Di
    Du, Zheng
    Fang, Yu-Qiang
    Guo, Fei
    Wang, Yu-Bo
    He, Yong
    Cen, Yuan
    Zeng, Fan
    BMC INFECTIOUS DISEASES, 2022, 22 (01)
  • [23] Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China
    Chen Hu
    Yu-Kai Liu
    Qi-Di Sun
    Zheng Du
    Yu-Qiang Fang
    Fei Guo
    Yu-Bo Wang
    Yong He
    Yuan Cen
    Fan Zeng
    BMC Infectious Diseases, 22
  • [24] Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial
    Hautefort, Charlotte
    Corre, Alain
    Poillon, Guillaume
    Jourdaine, Clement
    Housset, Juliette
    Eliezer, Michael
    Verillaud, Benjamin
    Slama, Dorsaf
    Ayache, Denis
    Herman, Philippe
    Yavchitz, Amelie
    Guillaume, Jessica
    Herve, Camille
    El Bakkouri, Wissame
    Salmon, Dominique
    Daval, Mary
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 136 : 70 - 76
  • [25] Clinical progression of patients with COVID-19 in Shanghai, China
    Chen, Jun
    Qi, Tangkai
    Liu, Li
    Ling, Yun
    Qian, Zhiping
    Li, Tao
    Li, Feng
    Xu, Qingnian
    Zhang, Yuyi
    Xu, Shuibao
    Song, Zhigang
    Zeng, Yigang
    Shen, Yinzhong
    Shi, Yuxin
    Zhu, Tongyu
    Lu, Hongzhou
    JOURNAL OF INFECTION, 2020, 80 (05) : E1 - E6
  • [26] High Prevalence of Deep Venous Thrombosis in Non-Severe COVID-19 Patients Hospitalized for a Neurovascular Disease
    Rouyer, Olivier
    Pierre-Paul, Irene Nora
    Balde, Amadou Talibe
    Jupiter, Damaris
    Bindila, Daniela
    Geny, Bernard
    Wolff, Valerie
    CEREBROVASCULAR DISEASES EXTRA, 2020, 10 (03): : 174 - 180
  • [27] Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China
    Zhu, Kongbo
    Ma, Shaolei
    Chen, Hui
    Xie, Jianfeng
    Huang, Dan
    Ma, Genshan
    Huang, Yingzi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [28] Comparison of initial clinic characteristics of hospitalized patients in Suzhou City during the COVID-19 Omicron wave with ancestral variant wave
    Gu, Binbin
    Yao, Lin
    Zhu, Xin-yun
    Zou, Tao
    Feng, Yan-jun
    Yan, Jin-yu
    Zhang, Jian-ping
    Tang, Pei-jun
    Chen, Cheng
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2022, 16
  • [29] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [30] Clinical outcomes of early remdesivir administration in hospitalized patients at high risk for severe COVID-19 during the Omicron wave
    La, Yeon Ju
    Oh, Won Sup
    Kim, Changhyup
    Lim, Myoung-nam
    Jeon, Yong Duk
    BMC INFECTIOUS DISEASES, 2025, 25 (01)